from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3080c/pknK

LFCtreatmentdescriptionclass of inhibitor

-0.101

Amikacinug/mL Amikacintranslation

-1.204

Cap5-10ug/mL Capreomycintranslation

-0.228

Rox10-50 ug/mL Roxithromycintranslation

0.929

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.267

Rif0.2-5ug/mL Rifampicintranscription

0.108

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.734

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.351

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.267

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.448

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.304

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.071

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.069

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

2.236

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.898

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.732

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.524

Nigericin50 uM Nigericinrespiration

0.302

TRC10-150 ug/mL Triclosanrespiration

1.336

TRZ10-25 ug/mL Thioridazinerespiration

-0.129

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.164

menadione6-10 ug/mL Menadionerespiration

-0.647

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.607

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.156

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.756

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.282

NRP_1Non-replicating persistence stage 1dosRassociated

0.742

Amp0.2mg/mL AmpicillincellWall

-0.463

Cephalexin20-100 ug/mL CephalexincellWall

-0.440

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.529

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.098

EMB10-20 ug/mL EthambutolcellWall

-0.719

Eta12-40 ug/mL EthionamidecellWall

-0.656

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.320

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.418

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.062

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.339

BZA0.12 mg/mL BenzamidearomaticAmides

0.425

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.432

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.385

H2O24 mM hydrogen peroxideDNAdamaging

-0.466

Levo10 ug/mL LevofloxacinDNAdamaging

-0.216

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.487

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.268

UVUV-irradiationDNAdamaging

-0.608

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.472

Antimycin12.5-50 ug/mL Antimycin A?

-0.525

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.495

PA_110-50 ug/mL Antitubercular compound PA-1?

0.304

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.593

PA8240.2-2 ug/mL PA-824?

1.443

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.632

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

-0.077

mercaptoethanol2 mM 2-Mercaptoethanol?

1.163

methoxatin10-20 ug/mL Methoxatin?